Cold Plasma Market Report 2025

The cold plasma market size has grown rapidly in recent years. It will grow from $3.16 billion in 2024 to $3.66 billion in 2025 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to rise in medical and healthcare sectors, growth in food industry, rise in aviation sector, emerging markets.

The cold plasma market size is expected to see rapid growth in the next few years. It will grow to $7.12 billion in 2029 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to increasing demand for water and air purification, growing electronics industry, increasing research and development activities, government support. Major trends in the forecast period include eco-friendly and sustainable solutions, nanotechnology integration, compact and portable devices, ai and automation integration, industry collaboration.

The expanding use of cold plasma technology across diverse industries is anticipated to drive the growth of the cold plasma market. This technology is gaining popularity in medical and industrial applications, particularly in healthcare devices and diagnostics. Cold plasma is increasingly recognized for its potential in addressing various challenges, including its application as a treatment for the ongoing COVID-19 pandemic. Its ability to eliminate bacteria, especially drug-resistant strains, makes it a promising solution for preventing infections and assisting in the treatment of chronic wounds. In the textile industry, cold plasma plays a role in the hydrophilization process for treating protective clothing and sterile materials, contributing to the reduction of microorganisms. The growing global geriatric population, as reported by the World Health Organization in October 2022, underscores the increased prevalence of conditions like diabetes and chronic wounds, further propelling the cold plasma market.

The surge in infectious diseases is set to be a driving force behind the growth of the cold plasma market. Cold plasma technology's capacity to eradicate bacteria and viruses holds significant importance in healthcare settings, offering potential solutions for reducing healthcare-associated infections and contributing to air purification. A notable example is the reported increase in tuberculosis (TB) cases in the United States, according to the Centers for Disease Control and Prevention in March 2023. The rising incidence of infectious diseases, coupled with the need for effective solutions, is expected to fuel the demand for cold plasma technologies.

Technological advancements are a significant trend gaining traction in the cold plasma market. Nordson Corporation, a US-based developer and manufacturer of dispensing equipment, introduced the MARCH MegaVIATM Plasma Treatment System for large panels used in printed circuit board manufacturing. The new MegaVIATM system offers a panel loading capacity increase of over 54% with only a 2% rise in footprint, featuring overall dimensions of 1652mm W x 1782mm D x 2326mm H. This new platform ensures high process reproducibility and uniformity in plasma treatment for PCB panels.

Major companies in the cold plasma market are concentrating on developing advanced technological solutions, such as cold plasma systems, to improve surface treatment, sterilization, and medical applications. Cold plasma systems produce reactive species that can alter surfaces, eliminate pathogens, and encourage wound healing in medical settings. For example, in April 2024, Mirari Doctor PTE LTD, a Singapore-based company focused on advanced digital health technologies and patient management systems, introduced Revolutionary Cold Plasma Technology for Skin Rejuvenation and Wound Healing. The MIRARI® Cold Plasma System provides healthcare professionals with a portable and user-friendly tool for targeted treatments, demonstrating considerable potential in dermatology, wound care, and cancer therapies. It has received approvals from the Thai FDA and Vietnam MOH, highlighting its safety, efficacy, and cost-effectiveness for improved patient care. Mirari Doctor aims to broaden its global reach to benefit a larger number of patients.

In June 2022, neoplas med GmbH, a Germany-based medical equipment manufacturing company, and Niterra Co., Ltd., a Japan-based automotive parts manufacturing company, formed a strategic partnership with a substantial investment. This collaboration is centered around neoplas med's cutting-edge therapy for chronic and infected wounds utilizing cold plasma. The kINPen MED plasma jet treatment, designed to accelerate wound healing, particularly in diabetic foot syndrome patients, boasts an impressive 59% success rate within six weeks - a substantial improvement over the 5% rate associated with standard therapy. Additionally, the treatment proves cost-effective, being up to 52% more affordable than conventional wound treatment. This significant advancement holds great promise for enhancing both wound healing outcomes and overall patient well-being.

Major companies operating in the cold plasma market include Ethicon Inc., Baxter International Inc., 3M Company, Smith & Nephew plc., Nordson Corporation, Plasma Etch Inc., Adtech Plasma Technology Co. Ltd., P2i Limited, Relyon Plasma GmbH, Henniker Plasma Treatment, Enercon Industries Corporation, AcXys Plasma Technologies, Plasmatreat GmbH, Europlasma NV, SOFTAL Corona & Plasma GmbH, UNIQAIR Technologies Ltd., CINOGY System GmbH, neoplas med GmbH, Leaflife Technology Co. Ltd., Nova Plasma Ltd., Tantec A/S, Surfx Technologies LLC, Coating Plasma Innovation, Ferrarini & Benelli Srl, terraplasma GmbH, Molecular Plasma Group, Advanced Plasma Solutions Co. Inc., PlasmaLeap Technologies, US Medical Innovations LLC, COMET Plasma Control Technologies.

Cold plasma, also known as non-thermal atmospheric pressure plasma, finds applications in various industries, including plastics and polymers, textiles, electronics, food and agriculture, and medicine. Cold plasma is a reactive gas containing ions, electrons, and neutral particles in the air, allowing the generation of ozone from oxygen molecules through electrical discharges in atmospheric gases.

The main types of cold plasma based on regime include atmospheric cold plasma and low-pressure cold plasma. Atmospheric cold plasma is ionized gas near room temperature, serving as a source of reactive species, neutral particles, electromagnetic fields, and controllable UV radiation. Cold plasma technologies encompass remote treatment, direct treatment, and electrode contact. These technologies are utilized in diverse medical applications such as wood healing, blood coagulation, dentistry, and cancer treatment. Additionally, cold plasma is employed by various end-users including the automotive, electronics and semiconductors, food processing and packaging, medical, aerospace, and polymers and plastics industries.

The cold plasma research report is one of a series of new reports that provides cold plasma statistics, including cold plasma industry global market size, regional shares, competitors with cold plasma shares, detailed cold plasma segments, market trends and opportunities, and any further data you may need to thrive in the cold plasma industry. This cold plasma research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Asia-Pacific was the largest region in the cold plasma market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cold plasma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cold plasma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The cold plasma market consists of sales of cold plasma derived from techniques such as corona discharge and plasma jet. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.